Peters, Remco P.H.De Vos, LindseyMaduna, Liteboho DanielMudau, MaandaKlausner, Jeffrey D.Kock, Marleen M.Medina-Marino, Andrew2018-07-202018-07-202017-12Peters RPH, de Vos L, Maduna L, Mudau M, Klausner JD, Kock MM, Medina- Marino A. 2017. Laboratory validation of Xpert Chlamydia trachomatis/Neisseria gonorrhoeae and Trichomonas vaginalis testing as performed by nurses at three primary health care facilities in South Africa. J Clin Microbiol 55:3563–3565. https://DOI.org/10.1128/JCM.01430-17.0095-1137 (print1098-660X (online)10.1128/JCM.01430-17http://hdl.handle.net/2263/65803The introduction of molecular diagnostic tests provides an important step to address the burden of sexually transmitted infections (STIs), especially Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Recently developed Xpert CT/NG (for C. trachomatis/N. gonorrhoeae) and TV (for T. vaginalis) assays provide opportunities to detect these STIs in resource-limited settings. When performed by staff at primary health care (PHC) facilities, patients can be provided results and treatment within 2 h.zh© 2017 Peters et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license.Antenatal care (ANC)Molecular diagnosticsScreeningHuman immunodeficiency virus (HIV)Sexually transmitted infection (STI)Sexually transmitted disease (STD)South Africa (SA)Trichomonas vaginalisChlamydia trachomatisNeisseria gonorrhoeaePrimary health care (PHC)Article